Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 21, 2014; 20(31): 10953-10959
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10953
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10953
Figure 1 Recurrence-free survival (A) and overall survival (B) of hepatitis B virus-related hepatocellular carcinoma patients after living donor liver transplantation and deceased donor liver transplantation.
LDLT: Living donor liver transplantation; DDLT: Deceased donor liver transplantation.
Figure 2 Recurrence-free survival (A) and overall survival (B) of hepatitis B virus-related hepatocellular carcinoma patients divided according to different criteria after living donor liver transplantation and deceased donor liver transplantation.
LDLT: Living donor liver transplantation; DDLT: Deceased donor liver transplantation; UCSF: University of California, San Francisco.
- Citation: Xiao GQ, Song JL, Shen S, Yang JY, Yan LN. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation. World J Gastroenterol 2014; 20(31): 10953-10959
- URL: https://www.wjgnet.com/1007-9327/full/v20/i31/10953.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i31.10953